Announces significant contract with Major Biopharmaceutical Company
BELGIUM, Wis., March 6 /PRNewswire-FirstCall/ -- Mach One Corporation (Pink Sheets: MNCN), is pleased to announce that its subsidiary, Modular Process Constructors LLC, is changing its name to MPS BioPharm to better reflect its vision, and announces that it received a contract and deposits from a major global biopharmaceutical and consumer health company.
The contract is for a Clean-In-Place (CIP) system that meets the stringent hygiene regulations demanded by the food, dairy, biotechnology and pharmaceutical industries. MPS BioPharm currently has open quotes for over $10 million in new business during the past 90 days.
Monte Tobin, CEO of Mach One Corporation said, "MPS BioPharm provides engineering and fabrication services to the highly regulated food and life sciences industries. This contract is one of many being quoted which support the vision of Mach One being a global leader in supplying goods and services for the betterment of health for animals and mankind."
Modular Process Constructors, LLC (now MPS-BioPharm) was acquired Feb. 19, 2009 and is part of Mach One's BioPharm Process Systems Group and engages in the design and manufacture of constructed systems for the biopharmaceutical industry. It offers process modules and skids, custom tanks and vessels, and sanitary stainless steel flow equipment, along with professional project management, design qualifications, detail design, component procurement, schedule metrics and reporting. With the addition of MPS-BioPharm, it enables Mach One to accelerate production of biopharmaceutical, Nutraceutical, and Bridge Iggs on a global basis. The BioPharm Process Systems Group is headquartered in Kenosha, Wisconsin.
About Mach One Corporation:
Mach One Corporation (www.machonecorp.com) is a global wellness company that provides biotechnology based solutions to help address one of the world's most pressing and costly needs--positive, long-term health and longevity benefits for humans and disease-threatened animals of commercial operations. While animal wellness, organic and sustainable products are our initial primary focus, we intend in the near future to add Nutraceuticals to our growing list of operating groups. As an ongoing objective we intend to be agile and swift in spotting business opportunities and respective businesses to expand our vision for positive contribution to global wellness.
Cautionary Statement: This news release may include certain "Forward-looking statements" within the meaning of Section 21E of the United States Securities Exchange Act, as amended. All statements, other than statements of historical fact, included in this release are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. This notice expressly qualifies all forward-looking statements in this release.
|SOURCE Mach One Corporation|
Copyright©2009 PR Newswire.
All rights reserved